8VPI
CamA Adenine Methyltransferase Complexed to Cognate Substrate DNA and Containing Quinoline-based SGI-1027 Analog 462
これはPDB形式変換不可エントリーです。
8VPI の概要
| エントリーDOI | 10.2210/pdb8vpi/pdb |
| 分子名称 | Site-specific DNA-methyltransferase (adenine-specific), DNA Strand II, DNA Strand I, ... (6 entities in total) |
| 機能のキーワード | dna adenine methylation, protein-dna complex, transferase, dna binding protein, dna binding protein-dna complex, dna binding protein/dna |
| 由来する生物種 | Clostridioides difficile 詳細 |
| タンパク質・核酸の鎖数 | 9 |
| 化学式量合計 | 232575.72 |
| 構造登録者 | |
| 主引用文献 | Zhou, J.,Chen, Q.,Ren, R.,Yang, J.,Liu, B.,Horton, J.R.,Chang, C.,Li, C.,Maksoud, L.,Yang, Y.,Rotili, D.,Zhang, X.,Blumenthal, R.M.,Chen, T.,Gao, Y.,Valente, S.,Mai, A.,Cheng, X. Quinoline-based compounds can inhibit diverse enzymes that act on DNA. Biorxiv, 2024 Cited by PubMed Abstract: DNA methylation, as exemplified by cytosine-C5 methylation in mammals and adenine-N6 methylation in bacteria, is a crucial epigenetic mechanism driving numerous vital biological processes. Developing non-nucleoside inhibitors to cause DNA hypomethylation is a high priority, in order to treat a variety of significant medical conditions without the toxicities associated with existing cytidine-based hypomethylating agents. In this study, we have characterized fifteen quinoline-based analogs. Notably, compounds with additions like a methylamine ( ) or methylpiperazine ( ) demonstrate similar low micromolar inhibitory potency against both human DNMT1 (which generates C5-methylcytosine) and CamA (which generates N6-methyladenine). Structurally, compounds and specifically intercalate into CamA-bound DNA via the minor groove, adjacent to the target adenine, leading to a substantial conformational shift that moves the catalytic domain away from the DNA. This study adds to the limited examples of DNA methyltransferases being inhibited by non-nucleotide compounds through DNA intercalation, following the discovery of dicyanopyridine-based inhibitors for DNMT1. Furthermore, our study shows that some of these quinoline-based analogs inhibit other enzymes that act on DNA, such as polymerases and base excision repair glycosylases. Finally, in cancer cells compound elicits DNA damage response via p53 activation. PubMed: 38617249DOI: 10.1101/2024.04.03.587980 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.89 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






